List of Excipients in API calcifediol
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing calcifediol
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| OPKO Pharmaceuticals LLC | RAYALDEE | calcifediol | 70301-1001 | ALCOHOL | 2034-03-14 |
| OPKO Pharmaceuticals LLC | RAYALDEE | calcifediol | 70301-1001 | BUTYLATED HYDROXYTOLUENE | 2034-03-14 |
| OPKO Pharmaceuticals LLC | RAYALDEE | calcifediol | 70301-1001 | CARRAGEENAN | 2034-03-14 |
| OPKO Pharmaceuticals LLC | RAYALDEE | calcifediol | 70301-1001 | DIACETYLTARTARIC AND FATTY ACID ESTERS OF GLYCEROL | 2034-03-14 |
| OPKO Pharmaceuticals LLC | RAYALDEE | calcifediol | 70301-1001 | FD&C BLUE NO. 1 | 2034-03-14 |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for calcifediol
Excipient focus: ALCOHOL
calcifediol drug variants containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| OPKO Pharmaceuticals LLC | calcifediol | 70301-1001 |
| >Company | >Ingredient | >NDC |
calcifediol drug variants not containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: BUTYLATED HYDROXYTOLUENE
calcifediol drug variants containing BUTYLATED HYDROXYTOLUENE
| Company | Ingredient | NDC |
|---|---|---|
| OPKO Pharmaceuticals LLC | calcifediol | 70301-1001 |
| >Company | >Ingredient | >NDC |
calcifediol drug variants not containing BUTYLATED HYDROXYTOLUENE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CARRAGEENAN
calcifediol drug variants containing CARRAGEENAN
| Company | Ingredient | NDC |
|---|---|---|
| OPKO Pharmaceuticals LLC | calcifediol | 70301-1001 |
| >Company | >Ingredient | >NDC |
calcifediol drug variants not containing CARRAGEENAN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: DIACETYLTARTARIC AND FATTY ACID ESTERS OF GLYCEROL
calcifediol drug variants containing DIACETYLTARTARIC AND FATTY ACID ESTERS OF GLYCEROL
| Company | Ingredient | NDC |
|---|---|---|
| OPKO Pharmaceuticals LLC | calcifediol | 70301-1001 |
| >Company | >Ingredient | >NDC |
calcifediol drug variants not containing DIACETYLTARTARIC AND FATTY ACID ESTERS OF GLYCEROL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 1
calcifediol drug variants containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| OPKO Pharmaceuticals LLC | calcifediol | 70301-1001 |
| >Company | >Ingredient | >NDC |
calcifediol drug variants not containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CORN STARCH
calcifediol drug variants containing HYDROXYPROPYL CORN STARCH
| Company | Ingredient | NDC |
|---|---|---|
| OPKO Pharmaceuticals LLC | calcifediol | 70301-1001 |
| >Company | >Ingredient | >NDC |
calcifediol drug variants not containing HYDROXYPROPYL CORN STARCH
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
calcifediol drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| OPKO Pharmaceuticals LLC | calcifediol | 70301-1001 |
| >Company | >Ingredient | >NDC |
calcifediol drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: ISOPROPYL ALCOHOL
calcifediol drug variants containing ISOPROPYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| OPKO Pharmaceuticals LLC | calcifediol | 70301-1001 |
| >Company | >Ingredient | >NDC |
calcifediol drug variants not containing ISOPROPYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: LAUROYL PEG-32 GLYCERIDES
calcifediol drug variants containing LAUROYL PEG-32 GLYCERIDES
| Company | Ingredient | NDC |
|---|---|---|
| OPKO Pharmaceuticals LLC | calcifediol | 70301-1001 |
| >Company | >Ingredient | >NDC |
calcifediol drug variants not containing LAUROYL PEG-32 GLYCERIDES
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MEDIUM-CHAIN TRIGLYCERIDES
calcifediol drug variants containing MEDIUM-CHAIN TRIGLYCERIDES
| Company | Ingredient | NDC |
|---|---|---|
| OPKO Pharmaceuticals LLC | calcifediol | 70301-1001 |
| >Company | >Ingredient | >NDC |
calcifediol drug variants not containing MEDIUM-CHAIN TRIGLYCERIDES
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MINERAL OIL
calcifediol drug variants containing MINERAL OIL
| Company | Ingredient | NDC |
|---|---|---|
| OPKO Pharmaceuticals LLC | calcifediol | 70301-1001 |
| >Company | >Ingredient | >NDC |
calcifediol drug variants not containing MINERAL OIL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PARAFFIN
calcifediol drug variants containing PARAFFIN
| Company | Ingredient | NDC |
|---|---|---|
| OPKO Pharmaceuticals LLC | calcifediol | 70301-1001 |
| >Company | >Ingredient | >NDC |
calcifediol drug variants not containing PARAFFIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
calcifediol drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| OPKO Pharmaceuticals LLC | calcifediol | 70301-1001 |
| >Company | >Ingredient | >NDC |
calcifediol drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM PHOSPHATE, DIBASIC
calcifediol drug variants containing SODIUM PHOSPHATE, DIBASIC
| Company | Ingredient | NDC |
|---|---|---|
| OPKO Pharmaceuticals LLC | calcifediol | 70301-1001 |
| >Company | >Ingredient | >NDC |
calcifediol drug variants not containing SODIUM PHOSPHATE, DIBASIC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SORBITAN
calcifediol drug variants containing SORBITAN
| Company | Ingredient | NDC |
|---|---|---|
| OPKO Pharmaceuticals LLC | calcifediol | 70301-1001 |
| >Company | >Ingredient | >NDC |
calcifediol drug variants not containing SORBITAN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SORBITOL
calcifediol drug variants containing SORBITOL
| Company | Ingredient | NDC |
|---|---|---|
| OPKO Pharmaceuticals LLC | calcifediol | 70301-1001 |
| >Company | >Ingredient | >NDC |
calcifediol drug variants not containing SORBITOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
calcifediol drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| OPKO Pharmaceuticals LLC | calcifediol | 70301-1001 |
| >Company | >Ingredient | >NDC |
calcifediol drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
calcifediol drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| OPKO Pharmaceuticals LLC | calcifediol | 70301-1001 |
| >Company | >Ingredient | >NDC |
calcifediol drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
